Global Molecular Quality Control Industry to 2029 – Rising Demand for External Standards Assessment Support Drives Market –


DUBLIN–(BUSINESS WIRE)–The “Molecular Quality Control Market Analysis by Product, Analyte Type by Application, End User and Region – Global Forecast to 2029” report has been added to from offer.

The Molecular Quality Control Market size is estimated to be USD 324 Million in 2021 and is expected to witness a CAGR of 9.17% during the forecast period 2022-2029.

Companies cited

  • F. Hoffmann-La Roche SA (Switzerland)

  • Bio-Rad Laboratories Inc. (USA)

  • Thermo Fisher Scientific Inc. (USA)

  • Randox Laboratories Ltd. (UK)

  • LGC Limited (UK)

  • Abbott Laboratories (USA)

  • Fortress Diagnostics (UK)

  • SERO AS (Norway)

  • Anchor Molecular (USA)

  • Ortho-Clinical Diagnostics Inc. (USA)

  • Quidel Corporation (USA)

  • Sun Diagnostics LLC (USA)

  • Seegene Inc. (South Korea)

  • ZeptoMetrix LLC (USA)

  • Qnostics (UK)

  • Bio-Techne Corporation (USA)

  • Microbiologics Inc. (USA)

  • Microbix Biosystems Inc. (Canada)

  • SpeedDx Pty. ltd. (Australia)

  • Maine Molecular Quality Controls Inc. (USA)

  • Grifols SA (Spain)

Increased adoption of third-party quality controls, growing number of accredited clinical laboratories, growing demand for external standards assessment support, increased government funding to cover genomics projects are some of the key drivers of market growth. Additionally, rising demand for personalized drugs, declining sequencing costs, and growing prevalence of infectious diseases, cancer, and genetic diseases are expected to drive the market growth in the near future. However, the limited hospital budget and additional costs associated with quality control are expected to restrain the market growth.

By product

Based on product, the market is divided into instrument-specific controls and independent controls. In 2021, the Independent Testing segment accounted for the highest revenue share due to the growing number of accredited laboratories and regulations from regulatory bodies for the application of quality controls to ensure the accuracy of test results of diagnosis.

By analyte type

On the basis of analyte type, the market is divided into multi-analyte controls and single analyte controls. In 2021, the single analyte segment accounted for the highest revenue share due to the benefits of using single analyte controls, including its ease of analysis and interpretation and minimal risk of cross-reactivity, and the widespread use of singleplex tests in hospitals.

By app

Based on application, the market is divided into oncology testing, genetic testing, infectious disease diagnostics and other applications. In 2021, the infectious disease diagnostics segment accounted for the highest revenue share due to the growing understanding of how to use molecular diagnostic tools to effectively stop the incidence and spread of infectious diseases, advancement in sophisticated testing for infectious diseases and an increase in the high prevalence of infectious diseases.

Per end user

On the basis of end-user, the market is categorized into hospitals, diagnostic laboratories, academic and research institutes, IVD and CRO manufacturers, etc. In 2021, the diagnostic laboratory segment accounted for the highest revenue share due to the growing number of licensed diagnostic laboratories.

Regional markets

In 2021, the North America region accounted for the highest revenue in the molecular quality control market and is expected to maintain its dominance over the forecast period. This is attributed to the growing acceptance of biosimulation, the development of healthcare infrastructure in the United States and Canada, the presence of leading players in this region, and government funding. The Asia-Pacific market is expected to show the fastest CAGR over the forecast period owing to the development of healthcare infrastructure, growth in disposable income, and growing healthcare awareness in this region.

Main topics covered:

1. Research methodology

2. Introduction: Molecular Quality Control

3. Executive Summary

4. Market dynamics

4.1. Market factors

4.2. Market restriction

4.3. Market opportunities

4.4. Market trends

4.5. Market challenges

5. Analysis of the market environment

5.1. Porter’s 5 forces analysis

5.2. PESTEL analysis

5.3. Value chain analysis

5.4. SWOT analysis

5.5. Reference

6. COVID-19 Impact Analysis: Molecular Quality Control Market

6.1. COVID-19: Overview

6.2. Impact of COVID-19 on the global market

6.3. Impact of COVID-19 on regional markets

7. Market Analysis by Product

8. Market Analysis by Analyte Type

9. Market Analysis by Application

10. Market Analysis by End User

11. Regional Market Analysis

11.1.Regional Market Trends

11.2.Regional market: comparative analysis

12. North America Molecular Quality Control Market

13. Europe Molecular Quality Control Market

14. Asia-Pacific Molecular Quality Control Market

15. Latin America Molecular Quality Control Market

16. MEA Molecular Quality Control Market

17. Competitor Analysis

17.1. Market share analysis, 2021 and 2029

17.2. Competitive mapping

17.3. Key Players Market Analysis

17.4. Main recent developments

18. Company Profiles

19. Conclusion and Recommendations

For more information on this report visit


Comments are closed.